Literature DB >> 22957307

RanBPM expression regulates transcriptional pathways involved in development and tumorigenesis.

Elnaz Atabakhsh1, Jean H Wang, Xu Wang, David E Carter, Caroline Schild-Poulter.   

Abstract

RanBPM is a ubiquitous protein that has been reported to regulate several cellular processes through interactions with various proteins. However, it is not known whether RanBPM may regulate gene expression patterns. As it has been shown that RanBPM interacts with a number of transcription factors, we hypothesized that it may have wide ranging effects on gene expression that may explain its function. To test this hypothesis, we generated stable RanBPM shRNA cell lines to analyze the effect of RanBPM on global gene expression. Microarray analyses were conducted comparing the gene expression profile of Hela and HCT116 RanBPM shRNA cells versus control shRNA cells. We identified 167 annotated genes significantly up- or down-regulated in the two cell lines. Analysis of the gene set revealed that down-regulation of RanBPM led to gene expression changes that affect regulation of cell, tissue, and organ development and morphology, as well as biological processes implicated in tumorigenesis. Analysis of Transcription Factor Binding Sites (TFBS) present in the gene set identified several significantly over-represented transcription factors of the Forkhead, HMG, and Homeodomain families of transcription factors, which have previously been demonstrated as having important roles in development and tumorigenesis. In addition, the combined results of these analyses suggested that several signaling pathways were affected by RanBPM down-regulation, including ERK1/2, Wnt, Notch, and PI3K/Akt pathways. Lastly, analysis of selected target genes by quantitative RT-qPCR confirmed the changes revealed by microarray. Several of the genes up-regulated in RanBPM shRNA cells encode proteins with known oncogenic functions, such as the RON tyrosine kinase, the adhesion molecule L1CAM, and transcription factor ELF3/ESE-1, suggesting that RanBPM functions as a tumor suppressor to prevent deregulated expression of these genes. Altogether, these results suggest that RanBPM does indeed function to regulate many genomic events that regulate embryonic, tissue, and cellular development as well as those involved in cancer development and progression.

Entities:  

Keywords:  ERK; Notch; RanBPM; Wnt; cancer; development; microarray

Year:  2012        PMID: 22957307      PMCID: PMC3433104     

Source DB:  PubMed          Journal:  Am J Cancer Res        ISSN: 2156-6976            Impact factor:   6.166


  91 in total

Review 1.  The hallmarks of cancer.

Authors:  D Hanahan; R A Weinberg
Journal:  Cell       Date:  2000-01-07       Impact factor: 41.582

2.  Full-sized RanBPM cDNA encodes a protein possessing a long stretch of proline and glutamine within the N-terminal region, comprising a large protein complex.

Authors:  H Nishitani; E Hirose; Y Uchimura; M Nakamura; M Umeda; K Nishii; N Mori; T Nishimoto
Journal:  Gene       Date:  2001-07-11       Impact factor: 3.688

3.  Summaries of Affymetrix GeneChip probe level data.

Authors:  Rafael A Irizarry; Benjamin M Bolstad; Francois Collin; Leslie M Cope; Bridget Hobbs; Terence P Speed
Journal:  Nucleic Acids Res       Date:  2003-02-15       Impact factor: 16.971

Review 4.  Rules for making human tumor cells.

Authors:  William C Hahn; Robert A Weinberg
Journal:  N Engl J Med       Date:  2002-11-14       Impact factor: 91.245

5.  Compromised HOXA5 function can limit p53 expression in human breast tumours.

Authors:  V Raman; S A Martensen; D Reisman; E Evron; W F Odenwald; E Jaffee; J Marks; S Sukumar
Journal:  Nature       Date:  2000-06-22       Impact factor: 49.962

Review 6.  Oncogenic signaling pathways activated by RON receptor tyrosine kinase.

Authors:  Alla Danilkovitch-Miagkova
Journal:  Curr Cancer Drug Targets       Date:  2003-02       Impact factor: 3.428

7.  HIPK2 associates with RanBPM.

Authors:  Ying Wang; E Marion Schneider; Xin Li; Irina Duttenhöfer; Klaus Debatin; Hubert Hug
Journal:  Biochem Biophys Res Commun       Date:  2002-09-13       Impact factor: 3.575

8.  Activation of Ras/Erk pathway by a novel MET-interacting protein RanBPM.

Authors:  Dakun Wang; Zaibo Li; Edward M Messing; Guan Wu
Journal:  J Biol Chem       Date:  2002-07-29       Impact factor: 5.157

9.  RanBPM, a nuclear protein that interacts with and regulates transcriptional activity of androgen receptor and glucocorticoid receptor.

Authors:  Mira A Rao; Helen Cheng; Alandra N Quayle; Hideo Nishitani; Colleen C Nelson; Paul S Rennie
Journal:  J Biol Chem       Date:  2002-10-01       Impact factor: 5.157

10.  PANTHER: a browsable database of gene products organized by biological function, using curated protein family and subfamily classification.

Authors:  Paul D Thomas; Anish Kejariwal; Michael J Campbell; Huaiyu Mi; Karen Diemer; Nan Guo; Istvan Ladunga; Betty Ulitsky-Lazareva; Anushya Muruganujan; Steven Rabkin; Jody A Vandergriff; Olivier Doremieux
Journal:  Nucleic Acids Res       Date:  2003-01-01       Impact factor: 16.971

View more
  10 in total

1.  Proteomic analysis of ubiquitination substrates reveals a CTLH E3 ligase complex-dependent regulation of glycolysis.

Authors:  Matthew E R Maitland; Miljan Kuljanin; Xu Wang; Gilles A Lajoie; Caroline Schild-Poulter
Journal:  FASEB J       Date:  2021-09       Impact factor: 5.834

Review 2.  Structural and Functional Insights into GID/CTLH E3 Ligase Complexes.

Authors:  Matthew E R Maitland; Gilles A Lajoie; Gary S Shaw; Caroline Schild-Poulter
Journal:  Int J Mol Sci       Date:  2022-05-24       Impact factor: 6.208

3.  Cloning, expression and purification of the low-complexity region of RanBP9 protein.

Authors:  Shailendra Dhakal; Krishna Sapkota; Faqing Huang; Vijayaraghavan Rangachari
Journal:  Protein Expr Purif       Date:  2020-03-23       Impact factor: 1.650

4.  Characterization of RanBPM molecular determinants that control its subcellular localization.

Authors:  Louisa M Salemi; Sandra O Loureiro; Caroline Schild-Poulter
Journal:  PLoS One       Date:  2015-02-06       Impact factor: 3.240

5.  RanBP9/TSSC3 complex cooperates to suppress anoikis resistance and metastasis via inhibiting Src-mediated Akt signaling in osteosarcoma.

Authors:  Huanzi Dai; Yang-Fan Lv; Guang-Ning Yan; Gang Meng; Xi Zhang; Qiao-Nan Guo
Journal:  Cell Death Dis       Date:  2016-12-29       Impact factor: 8.469

Review 6.  Cell signalling pathway regulation by RanBPM: molecular insights and disease implications.

Authors:  Louisa M Salemi; Matthew E R Maitland; Christina J McTavish; Caroline Schild-Poulter
Journal:  Open Biol       Date:  2017-06       Impact factor: 6.411

7.  The multi-subunit GID/CTLH E3 ubiquitin ligase promotes cell proliferation and targets the transcription factor Hbp1 for degradation.

Authors:  Fabienne Lampert; Diana Stafa; Algera Goga; Martin Varis Soste; Samuel Gilberto; Natacha Olieric; Paola Picotti; Markus Stoffel; Matthias Peter
Journal:  Elife       Date:  2018-06-18       Impact factor: 8.140

8.  The mammalian CTLH complex is an E3 ubiquitin ligase that targets its subunit muskelin for degradation.

Authors:  Matthew E R Maitland; Gabriel Onea; Christopher A Chiasson; Xu Wang; Jun Ma; Sarah E Moor; Kathryn R Barber; Gilles A Lajoie; Gary S Shaw; Caroline Schild-Poulter
Journal:  Sci Rep       Date:  2019-07-08       Impact factor: 4.379

9.  ESE-1 in Early Development: Approaches for the Future.

Authors:  Chan Mi Lee; Jing Wu; Yi Xia; Jim Hu
Journal:  Front Cell Dev Biol       Date:  2016-06-28

10.  Ran Binding Protein 9 (RanBP9) is a novel mediator of cellular DNA damage response in lung cancer cells.

Authors:  Dario Palmieri; Mario Scarpa; Anna Tessari; Rexhep Uka; Foued Amari; Cindy Lee; Timothy Richmond; Claudia Foray; Tyler Sheetz; Ashley Braddom; Christin E Burd; Jeffrey D Parvin; Thomas Ludwig; Carlo M Croce; Vincenzo Coppola
Journal:  Oncotarget       Date:  2016-04-05
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.